Zavegepant Hydrochloride Patent Expiration

1. Zavzpret patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7220862 PFIZER Calcitonin gene related peptide receptor antagonists
Jan, 2024

(5 months ago)

US8481546 PFIZER CGRP receptor antagonist
Oct, 2031

(7 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7314883 PFIZER Anti-migraine treatments
Dec, 2023

(7 months ago)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Mar 09, 2028

NCE-1 date: 10 March, 2027

Market Authorisation Date: 09 March, 2023

Treatment: Administration of zavegepant for acute treatment of migraine with or without aura

Dosage: SPRAY, METERED

More Information on Dosage

ZAVZPRET family patents

Family Patents